$34.42 +0.49 (%) Novo Nordisk Shs Sponsored American DepositReceipt Repr 1 Sh -B- - New York Stock Exchange, Inc.

Dec. 5, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. 5 Pharma Stocks In Focus On World Diabetes Day

    TalkMarkets | Nov. 14, 2016 | 13:21PM EST
  2. Trump Triumphs

    TalkMarkets | Nov. 9, 2016 | 21:28PM EST
  3. Buy Health Care Now? It All Depends On The Election

    TalkMarkets | Nov. 7, 2016 | 01:10AM EST
  4. Pricing Issues Continue To Weigh On The Pharma Sector

    TalkMarkets | Nov. 5, 2016 | 20:01PM EST
  5. Drugs, Finance, Cars, And Fuel

    TalkMarkets | Nov. 1, 2016 | 11:57AM EST
  6. The Daily Shot And Data - October 31, 2016

    TalkMarkets | Oct. 31, 2016 | 10:07AM EST
  7. Global Roundup: Roche, Vale, Novo Nordisk, Teva, Benitec Et Al

    TalkMarkets | Oct. 21, 2016 | 19:05PM EST
  8. Stocks Up After 1st Presidential Debate; Why Tesla Looks Healthiest In Weeks

    IBD | Sep. 27, 2016 | 10:38AM EST
  9. Novo Nordisk, Weyerhaeuser Earnings, Jobs Report On Tap Friday

    Investors Business Daily | Aug. 4, 2016 | 11:26AM EST
  10. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 09:44AM EST
  11. My Favorite Health Care Stocks

    GuruFocus | Jul. 12, 2016 | 14:26PM EST
  12. Benzinga's Top Downgrades

    Benzinga | Feb. 8, 2016 | 09:38AM EST
  13. Worst Performing Industries For February 4, 2016

    Benzinga | Feb. 4, 2016 | 11:37AM EST
  14. The 2016 Nintai Charitable Trust Portfolio: Annual Review

    GuruFocus | Jan. 18, 2016 | 15:36PM EST
  15. Novo Nordisk Files for Regulatory Approval Of Long-Acting Factor IX in EU for Treatment of Haemophilia B

    Benzinga | Jan. 7, 2016 | 05:58AM EST
  16. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  17. Novo Nordisk Fourth Phase 3a Trial with Semaglutide in People with Type 2 Diabetes Shows Drug Safe, Well-Tolerated

    Benzinga | Dec. 17, 2015 | 04:37AM EST
  18. Jim Simons' Top Holdings Include VeriSign, Chipotle

    GuruFocus | Dec. 15, 2015 | 17:42PM EST
  19. Novo Nordisk Submits NDA to FDA for Faster-Acting Insulin Aspart for Treatment of Type 1, 2 Diabetes

    Benzinga | Dec. 9, 2015 | 04:19AM EST
  20. Amazon, Alibaba, Facebook: A Top Mutual Fund's Bets

    IBD | Dec. 2, 2015 | 18:16PM EST
  21. Ablynx Announces Nanobody Drug Discovery Collaboration, Licence Agreement With Novo Nordisk

    Benzinga | Nov. 25, 2015 | 04:23AM EST
  22. Vestas, Novo Lead As Denmark Stocks Outpace Peers

    IBD | Nov. 19, 2015 | 17:44PM EST
  23. Value Investing in BioPharma

    GuruFocus | Nov. 18, 2015 | 13:14PM EST
  24. Diabetes hits drugmakers

    IBD | Oct. 29, 2015 | 17:51PM EST
  25. Sanofi, Novo Nordisk Slide On Diabetes Headwinds

    IBD | Oct. 29, 2015 | 11:40AM EST
  26. Jim Simons' Five Most-Heavily Weighted Holdings

    GuruFocus | Oct. 21, 2015 | 18:04PM EST
  27. Ken Fisher Reduces Stake in Toyota, Increases Position in Anheuser-Busch

    GuruFocus | Oct. 20, 2015 | 17:51PM EST
  28. Emisphere Signs License Agreement With Novo Nordisk to Develop Oral Formulations of Four Molecules Targeting Metabolic Indications and Amends GLP-1 Agreement

    Benzinga | Oct. 15, 2015 | 07:26AM EST
  29. Warren Buffett Not Top 100 CEO; Ex VW CEO Is No. 20

    IBD | Oct. 12, 2015 | 12:33PM EST
  30. Novo Nordisk Says Second Phase 3A Trial With Semaglutide in People With Type 2 Diabetes Achieved Objective

    Benzinga | Sep. 25, 2015 | 03:19AM EST
  31. Jim Simons and Ken Fisher Decrease Exposure on Novo Nordisk A/S

    GuruFocus | Sep. 14, 2015 | 11:50AM EST
  32. Benzinga's Top Initiations

    Benzinga | Aug. 28, 2015 | 08:33AM EST
  33. US Stock Futures Slip Ahead Of Economic Data

    Benzinga | Aug. 14, 2015 | 06:11AM EST
  34. Genmab Enters Commercial License Agreement with Novo Nordisk for DuoBody Technology

    Benzinga | Aug. 14, 2015 | 05:39AM EST
  35. More Pharma Buyouts Ahead? 3 Top Stocks In Buy Range

    IBD | Aug. 3, 2015 | 17:21PM EST
  36. Six International Leaders Preparing To Report Results

    IBD | Jul. 30, 2015 | 17:23PM EST
  37. Nintai Returns: Q2 2015

    GuruFocus | Jul. 1, 2015 | 12:11PM EST
  38. Top Europe Stocks Rally On Greece Bailout Hopes

    IBD | Jun. 22, 2015 | 14:17PM EST
  39. Jim Simons' Top 3 Positions and One That Doubled Return

    GuruFocus | Jun. 10, 2015 | 15:33PM EST
  40. Weekly 52-Week Highs Highlight: ALTR, AIG, LUX, NVO, EXPE

    GuruFocus | May. 3, 2015 | 22:28PM EST
  41. Gilead's Strong Profit Tops Mixed Drug maker Reports

    IBD | Apr. 30, 2015 | 17:50PM EST
  42. Teva, Celgene, Novo Nordisk, Shire Report Q1 Earnings

    IBD | Apr. 30, 2015 | 09:48AM EST
  43. Novo Nordisk Posts Rise In Profit

    Benzinga | Apr. 30, 2015 | 05:06AM EST
  44. MannKind Looks Good For Long Term Investors

    GuruFocus | Apr. 29, 2015 | 11:37AM EST
  45. Novo Nordisk Will Repurchase Shares

    Benzinga | Apr. 22, 2015 | 07:35AM EST
  46. Successful diabetes drug trial

    IBD | Feb. 20, 2015 | 18:40PM EST
  47. Novo Nordisk Pops On Successful Diabetes Drug Trial

    IBD | Feb. 20, 2015 | 11:42AM EST
  48. Novo Nordisk Announces Positive Phase 2 Trial Results, Shares Spike Higher

    Benzinga | Feb. 20, 2015 | 11:14AM EST
  49. Morning Market Gainers

    Benzinga | Feb. 20, 2015 | 09:46AM EST
  50. Friday #PreMarket Movers: Arista Networks Up, CollabRx Down

    Benzinga | Feb. 20, 2015 | 09:00AM EST
Trading Center